Advancing Legislation on Drug Pricing — Is There a Path Forward?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advancing Legislation on Drug Pricing — Is There a Path Forward?

Published:2019-11-28 Issue:22 Volume:381 Page:2081-2084
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Dusetzina Stacie B.¹,Oberlander Jonathan¹

Affiliation:

1. From the Department of Health Policy, Vanderbilt University School of Medicine, Nashville (S.B.D.), and the Department of Social Medicine, School of Medicine, and the Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill (J.O.).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp1914044

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reforming the Medicare Part D Benefit Design: Financial Implications for Beneficiaries, Private Plans, Drug Manufacturers, and the Federal Government;Journal of Health Politics, Policy and Law;2022-07-14

2. Drug Prices and Value of Oncology Drugs in Italy;Value in Health;2021-09

3. 60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad;Research in Social and Administrative Pharmacy;2021-08

4. The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump Administration;Journal of Health Politics, Policy and Law;2021-05-21

5. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs;JAMA Network Open;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP